Since launching in 2018, hospital-owned Civica Rx works with about a third of the nation's hospitals and manufactures 80 drugs facing shortages, NBC affiliate KSL-TV reported Oct. 22.
Seven health systems formed the pharmaceutical company after struggling for years with recurring drug shortages. The first goal was to make 14 generics constantly in short supply for hospitals, and 19 systems were founding members.
Now, some governments and hundreds of hospitals are buying from Civica Rx.
Dan Liljenquist, the chief strategy officer for Salt Lake City-based Intermountain Health, volunteer board chair of Civica Rx and a former Utah senator, told KSL-TV Civica Rx plans to scale up operations at its Petersburg, Va.-based manufacturing plant.
Pediatric cancer therapies, penicillin and low-cost insulins are next on the docket, Mr. Liljenquist said.